Cargando…

Adenosine A(2A) receptor inhibition reduces synaptic and cognitive hippocampal alterations in Fmr1 KO mice

In fragile X syndrome (FXS) the lack of the fragile X mental retardation protein (FMRP) leads to exacerbated signaling through the metabotropic glutamate receptors 5 (mGlu5Rs). The adenosine A(2A) receptors (A(2A)Rs), modulators of neuronal damage, could play a role in FXS. A synaptic colocalization...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferrante, Antonella, Boussadia, Zaira, Borreca, Antonella, Mallozzi, Cinzia, Pedini, Giorgia, Pacini, Laura, Pezzola, Antonella, Armida, Monica, Vincenzi, Fabrizio, Varani, Katia, Bagni, Claudia, Popoli, Patrizia, Martire, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864914/ https://www.ncbi.nlm.nih.gov/pubmed/33547274 http://dx.doi.org/10.1038/s41398-021-01238-5

Ejemplares similares

Fmr1-KO mice failure to detect object novelty associates with a post-test decrease of structural and synaptic plasticity upstream of the hippocampus
por: Borreca, Antonella, et al.
Publicado: (2023)

Role of Adenosine A(2A) Receptors in Modulating Synaptic Functions and Brain Levels of BDNF: a Possible Key Mechanism in the Pathophysiology of Huntington's Disease
por: Tebano, Maria Teresa, et al.
Publicado: (2010)

Adenosine A(2A) receptors modulate BDNF both in normal conditions and in experimental models of Huntington’s disease
por: Potenza, R. L., et al.
Publicado: (2007)

Insight into the Role of the STriatal-Enriched Protein Tyrosine Phosphatase (STEP) in A(2A) Receptor-Mediated Effects in the Central Nervous System
por: Domenici, Maria Rosaria, et al.
Publicado: (2021)

Adenosine A(2A) receptor stimulation restores cell functions and differentiation in Niemann-Pick type C-like oligodendrocytes
por: De Nuccio, Chiara, et al.
Publicado: (2019)

Comparative Behavioral Phenotypes of Fmr1 KO, Fxr2 Het, and Fmr1 KO/Fxr2 Het Mice
por: Saré, Rachel Michelle, et al.
Publicado: (2019)

Anxiolytic properties of A(1) adenosine receptor PAMs
por: Vincenzi, Fabrizio, et al.
Publicado: (2016)

Adenosine and Inflammation: Here, There and Everywhere
por: Pasquini, Silvia, et al.
Publicado: (2021)

Fmr1 KO Mice as a Possible Model of Autistic Features
por: Bernardet, Maude, et al.
Publicado: (2006)

Myelin Defects in Niemann–Pick Type C Disease: Mechanisms and Possible Therapeutic Perspectives
por: Bernardo, Antonietta, et al.
Publicado: (2021)

Homeostatic Intrinsic Plasticity Is Functionally Altered in Fmr1 KO Cortical Neurons
por: Bülow, Pernille, et al.
Publicado: (2019)

Targeting Adenosine Receptors: A Potential Pharmacological Avenue for Acute and Chronic Pain
por: Vincenzi, Fabrizio, et al.
Publicado: (2020)

Cellular and synaptic phenotypes lead to disrupted information processing in Fmr1-KO mouse layer 4 barrel cortex
por: Domanski, Aleksander P. F., et al.
Publicado: (2019)

Hyperexcitability and Loss of Feedforward Inhibition Contribute to Aberrant Plasticity in the Fmr1KO Amygdala
por: Svalina, Matthew N., et al.
Publicado: (2021)

Functional Interaction between Adenosine A(2A) and mGlu(5) Receptors Mediates STEP Phosphatase Activation and Promotes STEP/mGlu(5)R Binding in Mouse Hippocampus and Neuroblastoma Cell Line
por: Mallozzi, Cinzia, et al.
Publicado: (2023)

Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications
por: Pasquini, Silvia, et al.
Publicado: (2022)

Sub-synaptic, multiplexed analysis of proteins reveals Fragile X related protein 2 is mislocalized in Fmr1 KO synapses
por: Wang, Gordon X, et al.
Publicado: (2016)

A sound-driven cortical phase-locking change in the Fmr1 KO mouse requires Fmr1 deletion in a subpopulation of brainstem neurons
por: Holley, Andrew J., et al.
Publicado: (2022)

In Vivo Volume Dynamics of Dendritic Spines in the Neocortex of Wild-Type and Fmr1 KO Mice
por: Ishii, Kazuhiko, et al.
Publicado: (2018)

Pharmacology of Adenosine Receptors: Recent Advancements
por: Vincenzi, Fabrizio, et al.
Publicado: (2023)

Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets
por: Pasquini, Silvia, et al.
Publicado: (2022)

Depressed nNOS expression during spine transition in the developing hippocampus of FMR1 KO mice
por: Xu, Qin, et al.
Publicado: (2012)

Impaired Adaptation and Laminar Processing of the Oddball Paradigm in the Primary Visual Cortex of Fmr1 KO Mouse
por: Pak, Alexandr, et al.
Publicado: (2021)

A(1) Adenosine Receptor Partial Agonists and Allosteric Modulators: Advancing Toward the Clinic?
por: Vincenzi, Fabrizio, et al.
Publicado: (2020)

P2X7 Receptor Agonist 2′(3′)-O-(4-Benzoylbenzoyl)ATP Differently Modulates Cell Viability and Corticostriatal Synaptic Transmission in Experimental Models of Huntington’s Disease
por: Martire, Alberto, et al.
Publicado: (2021)

Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by a BKCa channel opener molecule
por: Hébert, Betty, et al.
Publicado: (2014)

Testing Fmr1(KO) Phenotypes in Response to GSK3 Inhibitors: SB216763 versus AFC03127
por: Westmark, Pamela R., et al.
Publicado: (2021)

Largely unaffected auditory and visual sensory processing phenotypes in the evoked potentials of Fmr1 KO2 mice
por: Kat, Renate, et al.
Publicado: (2022)

Evaluating the effect of R-Baclofen and LP-211 on autistic behavior of the BTBR and Fmr1-KO mouse models
por: Sharghi, Shirin, et al.
Publicado: (2023)

CNS-dominant human FMRP isoform rescues seizures, fear, and sleep abnormalities in Fmr1-KO mice
por: Wong, Hayes, et al.
Publicado: (2023)

A(2A) adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosus
por: Bortoluzzi, Alessandra, et al.
Publicado: (2016)

Efficient Delivery of FMR1 across the Blood Brain Barrier Using AAVphp Construct in Adult FMR1 KO Mice Suggests the Feasibility of Gene Therapy for Fragile X Syndrome
por: Chadman, Kathryn K., et al.
Publicado: (2023)

Is the functional interaction between adenosine A(2A) receptors and metabotropic glutamate 5 receptors a general mechanism in the brain? Differences and similarities between the striatum and the hippocampus
por: Tebano, M. T., et al.
Publicado: (2006)

FMRP-Driven Neuropathology in Autistic Spectrum Disorder and Alzheimer's disease: A Losing Game
por: Bleuzé, Louis, et al.
Publicado: (2021)

A(3) Adenosine and P2X7 Purinergic Receptors as New Targets for an Innovative Pharmacological Therapy of Malignant Pleural Mesothelioma
por: Vincenzi, Fabrizio, et al.
Publicado: (2021)

Reversal of Fragile X Phenotypes by Manipulation of AβPP/Aβ Levels in Fmr1(KO) Mice
por: Westmark, Cara J., et al.
Publicado: (2011)

The effect of an mGluR5 inhibitor on procedural memory and avoidance discrimination impairments in Fmr1 KO mice
por: Veloz, M F Vinueza, et al.
Publicado: (2012)

New Insights Into the Role of Ca(v)2 Protein Family in Calcium Flux Deregulation in Fmr1-KO Neurons
por: Castagnola, Sara, et al.
Publicado: (2018)

Piperazine- and Piperidine-Containing Thiazolo[5,4-d]pyrimidine Derivatives as New Potent and Selective Adenosine A(2A) Receptor Inverse Agonists
por: Varano, Flavia, et al.
Publicado: (2020)

An Open Question: Is the A(2A) Adenosine Receptor a Novel Target for Alzheimer’s Disease Treatment?
por: Merighi, Stefania, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rfltoi5u9a391jnveg4l0g3kgv